mylablogo
Diagnostics

Protect your Workforce with Safety & Convenience of NASOVAC-S4

India’s first Quadrivalent Needle-Free Intranasal Flu Vaccine

1 Billion

Cases of influenza are estimated to occur globally

5% - 10%

Unvaccinated adults are infected annually

20% - 30%

Unvaccinated children are infected annually
Book your Flu Vaccination

NASOVAC-S4

Introducing NASOVAC-S4, India’s FIRST quadrivalent needle-free influenza (seasonal flu) vaccine. Covers 2 Type A (H1N1 and H3N2) & 2 Type B (Victoria and Yamagata lineage)

Benefits

NASOVAC-S4 Product Details

NASOVAC-S4 is a live attenuated quadrivalent vaccine that protects from four virus strains
Dosage
A single intranasal dose of 0.5 ml, administered as 0.25 ml per nostril
Storage Requirement
Storage Requirements: Store in a refrigerator at 2ºC – 8ºC. Do not freeze

NASOVAC-S4 Administration Method

Administering NASOVAC-S4 is simple and convenient. Follow these easy steps
APPLY FOR THIS JOB
Are you ready for this new challenge?
Thank you for choosing us!
Our team will contact you using the details provided below at the earliest opportunity.